國家衛生研究院 NHRI:Item 3990099045/11148

NHRI > National Institute of Environmental Health Sciences > Shu-Li Wang > Conference Papers/Meeting Abstract > Item 3990099045/11148

Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/11148

Title:	Prenatal and postnatal exposure to perfluoroalkyl substances and antibody concentrations with mass vaccination in 5, 8, 11 and 14 year-old children in Taiwan
Authors:	Wang, SLJ;Lin, S;Wen, HJ;Guo, YL
Contributors:	National Institute of Environmental Health Sciences
Abstract:	RATIONALE: Perﬂuoroalkyl substances (PFASs) are wide spread persistant compounds which have half-life of 3-15 years in human bodies. PHASs have been found associated with decreased toxoid antibody concentrations, and increased atopy risk in children. We aim to examine the association between PFASs exposure and children antibody levels. METHODS: We utilized a birth cohort established in 2000-2001 consisting 610 pregnant women and their children followed at 2, 5, 8, 11, and 14 years old. Due to lost-to follow-up and lake of sufﬁcient serum, 376 and 69 children have PFASs quantiﬁed at birth and 8-year old, respectively. Antibody concentrations were analyzed for 90, 104, 69 and 92 children at 5, 8, 11, and 14 years, respectively. The last time mass vaccination was during 5-6 year-old in Taiwan. Co-exposure of phthalate, inorganic arsenic, chromium and cadmium was considered. RESULTS: PFOS and PFOA levels were generally slightly lower but PFNA was higher than in the US and northern Europe. High correlation and comparable PFASs and antibody concentrations between maternal and cord blood was established, apart from that cord blood had much higher PFHxS than maternal venous blood (median, 22.8 vs. 1.0 ng/mL). Preliminary results showed cord blood PFASs appear to associate with decreased antibody against tetanus, rubella and HBV. For example cord blood PFDoA was correlated with decreased tetanus antibody concentrations at 5 and 14 years, with r 5 -0.31 (p < 0.01) and -0.37 (p < 0.001), respectively. CONCLUSIONS: Clinical management concerning re-booster of certain vaccinations may have PHASs exposure considered because children immune Th1/Th2 might be unbalanced. Further mechanistic study is warranted.
Date:	2018-02
Relation:	Journal of Allergy and Clinical Immunology. 2018 Feb;141(2, Suppl.):AB17.
Link to:	https://doi.org/10.1016/j.jaci.2017.12.055
JIF/Ranking 2023:	http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0091-6749&DestApp=IC2JCR
Cited Times(WOS):	https://www.webofscience.com/wos/woscc/full-record/WOS:000429306700054
Appears in Collections:	[Shu-Li Wang] Conference Papers/Meeting Abstract [Hui-Ju Wen] Conference Papers/Meeting Abstract [Yue-Liang Guo] Conference Papers/Meeting Abstract

Files in This Item:

File	Description	Size	Format
ISI000429306700054.pdf		156Kb	Adobe PDF	294	View/Open

Loading...